Topaicí molta laistigh de do chuardach.
Topaicí molta laistigh de do chuardach.
- COVID-19
- SARS-CoV-2 142
- COVID-19 (Disease) 130
- Research 82
- Coronavirus infections 76
- Coronavirus Infections 74
- immunology 64
- COVID-19 Vaccines 54
- Betacoronavirus 48
- COVID-19 Pandemic, 2020- 48
- prevention & control 48
- virology 48
- Development 46
- Coronaviruses 44
- Vaccination 44
- Pandemics 42
- Vaccines 42
- Treatment 32
- Immunological aspects 30
- drug therapy 30
- epidemiology 30
- Drug Development 26
- Mutation 26
- genetics 26
- Disease Outbreaks 24
- Pneumonia, Viral 24
- drug effects 24
- transmission 22
- Clinical trials 20
- Communicable Diseases, Emerging 18
-
21
The role of Neuropilin-1 as a SARS-CoV-2-specific endocytosis potentiator
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
22
SARS-CoV-2 vaccine rollout campaigns
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
23
COVID-19 epidemiology and variants new challenges and future of the pandemic /
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
24
Interspecies transmission of SARS-CoV-2
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
25
Human movement patterns and local spread of COVID-19
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
26
Complement activation in COVID-19
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
27
SARS-CoV-2 mutations phenotypes and implications for vaccine development /
Foilsithe / Cruthaithe 2021Faigh an téacs iomlán
Series
Leictreonach Fuaim -
28
The immune system response to the SARS-CoV-2 virus December 2020 update /
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
29
-
30
Triage and end of life care planning in COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
31
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
32
The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
33
The neurological symptoms of COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
34
Imperial College London's saRNA Vaccine - COVAC1
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
35
Potential long-term health effects of a SARS-CoV-2 infection
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
36
Interferon-α2b as a therapy for COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
37
The COVID-19 coronavirus outbreak October 2020 update /
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
38
Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
39
Rheumatic diseases and COVID-19
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim -
40
The cardiovascular complications of SARS-CoV-2 infection
Foilsithe / Cruthaithe 2020Faigh an téacs iomlán
Series
Leictreonach Fuaim